COMPARE · Reviewed August 3, 2026
VEEV vs WAY
Verdict: Side-by-side breakdown using the Bull Rankings model. VEEV scored 81.5, WAY scored 58.9 — VEEV leads.
Compare another set
VEEV
Veeva Systems Inc.
81.5
$210.94 · $34.3B
fundamentals as of
Score gap
22.6
VEEV leads
WAY
Waystar Holding Corp.
58.9
$23.40 · $4.5B
fundamentals as of
The model, pillar by pillar (0–100 each)
VEEV
stronger →← stronger
WAY
77
Qualityreturns · margins · balance sheet
47
94
Growthrevenue & earnings expansion
95
74
Valuevaluation vs sector peers
45
VEEV is stronger on 2 of 3 pillars.
Fundamentals, head-to-head
VEEV
WAY
$1.7bC+
FCF
$246mC
+16.2%B+
Rev
+19.2%B+
0.01A-
D/E
0.37B
37.5xC+
P/E
33.4xC+
0.92B+
PEG
1.96C+
Winner per row is the stronger grade in our model; a tie or a missing value shows no highlight.
Valuation · DCF cross-check
VEEV
WAY
11% above
Price vs fair valuelower is cheaper
0% above
~10%/yr
Growth the price implies10-yr FCF · lower = less priced in
~8%/yr
-18%
1-yr DCF upside
-12%
-10%
5-yr DCF upside
0%
+4%
10-yr DCF upside
+19%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
VEEV
No notable signals flagged.
WAY
Why this score
- Diluting shareholders
- Short track record
The companies
VEEVVeeva Systems Inc.
Why now
Health Information Services · market cap $34.3b. Down 32% from 52-week high of $310.50 — deep drawdown territory. Revenue growing +16%, comfortably above the S&P median. PEG 0.92 — paying under fair value for the growth rate. 28 sell-side analysts rate this a Buy with a mean 1-yr target of $244.14 (implying +16% upside).
Moat
Net margin 28% sits well above the S&P median (~11%) — suggests structural pricing advantage or cost discipline competitors can't quickly close. ROE 13% meets the long-run market sustainable threshold — solid but not differentiated; the durability comes from elsewhere. FCF converts 177% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
Down 32% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up. Trailing P/E 37x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates. P/S 10.3x embeds aggressive forward growth — disappointing top-line guidance would compress the multiple hard.
WAYWaystar Holding Corp.
Why now
Health Information Services · market cap $4.5b. Down 44% from 52-week high of $41.47 — deep drawdown territory. Revenue growing +19%, comfortably above the S&P median. 23 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $33.22 (implying +42% upside).
Moat
FCF converts 183% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
Down 44% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up. Trailing P/E 33x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates. ROE 3% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.